Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma

被引：0
|
作者：
Shindoh, Junichi [1 ]
机构：
[1] Toranomon Gen Hosp, Dept Surg Gastroenterol, Hepatobiliary Surg Div, Tokyo, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / 04期
关键词：
HEPATOCELLULAR-CARCINOMA; SURVIVAL;
D O I：
10.1245/s10434-019-08145-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：983 / 984
页数：2
相关论文
共 50 条
  • [31] Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis
    Cillo, Umberto
    Spolverato, Gaya
    Vitale, Alessandro
    Ejaz, Aslam
    Lonardi, Sara
    Cosgrove, David
    Pawlik, Timothy M.
    WORLD JOURNAL OF SURGERY, 2015, 39 (10) : 2500 - 2509
  • [32] Apatinib treatment in extensive metastatic advanced intrahepatic cholangiocarcinoma: a case report
    Shu, Yefei
    Yang, Wei
    Yi, Li
    Xu, Xiaofeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9468 - 9472
  • [33] Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma
    Masoud, Sabran J.
    Rhodin, Kristen E.
    Kanu, Elishama
    Bao, Jiayin
    Eckhoff, Austin M.
    Bartholomew, Alex J.
    Howell, Thomas C.
    Aykut, Berk
    Kosovec, Juliann E.
    Palta, Manisha
    Befera, Nicholas T.
    Kim, Charles Y.
    Herbert, Garth
    Shah, Kevin N.
    Nussbaum, Daniel P.
    Blazer, Dan G., III
    Zani, Sabino
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (11) : 6639 - 6646
  • [34] Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
    Zhang, Zhuochao
    Wang, Gaofei
    Du, Lei
    Zhao, Jie
    Pan, Lichao
    Zhang, Gong
    Wang, Fei
    Liu, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
    Shimizu, Shosei
    Okumura, Toshiyuki
    Oshiro, Yoshiko
    Fukumitsu, Nobuyoshi
    Fukuda, Kuniaki
    Ishige, Kazunori
    Hasegawa, Naoyuki
    Numajiri, Haruko
    Murofushi, Keiko
    Ohnishi, Kayoko
    Mizumoto, Masashi
    Nonaka, Tetsuo
    Ishikawa, Hitoshi
    Sakurai, Hideyuki
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [36] Identification of Homer1 as a Potential Prognostic Marker for Intrahepatic Cholangiocarcinoma
    Wu, San-Yun
    Yu, Ming-Xia
    Li, Xiao-Gai
    Xu, Shu-Fang
    Shen, Ji
    Sun, Zhen
    Zhou, Xin
    Chen, Xing-Zhen
    Tu, Jian-Cheng
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 3299 - 3304
  • [37] CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
    Shimada, Mitsuo
    Sugimoto, Koji
    Iwahashi, Shuichi
    Utsunomiya, Tohru
    Morine, Yuji
    Imura, Satoru
    Ikemoto, Tetsuya
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (08) : 896 - 902
  • [38] Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma
    Sebastian, Nikhil T.
    Tan, Yubo
    Miller, Eric D.
    Williams, Terence M.
    Diaz, Dayssy Alexandra
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 19 : 66 - 71
  • [39] Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma
    Li, Jun
    Lu, Jiongjiong
    Lv, Shaodong
    Sun, Shujun
    Liu, Caifeng
    Xu, Feng
    Sun, Haiying
    Yang, Jiamei
    Wang, Xinjun
    Zhong, Xingyang
    Lu, Junhua
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [40] A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma
    Pan, Ting-Ting
    Wang, Wei
    Jia, Wei-Dong
    Xu, Ge-Liang
    ONCOLOGY LETTERS, 2017, 13 (05) : 2957 - 2964
12345